Skip to content
2000
Volume 21, Issue 6
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

The current pandemic of COVID-19 caused by SARS-Cov-2 has posed a severe threat to the whole world with its highly infectious, progressive nature with up to 10% mortality rates. The severity of the situation faced by the whole world and the lack of efficient therapeutics to treat this viral disease have led the WHO to depend on the drug-repurposing approach to tackle this major global health problem. This review aims at highlighting the various synthetic approaches employed for the synthesis of these FDA approved drugs that have been presently used for COVID-19 treatment. Additionally, a brief overview of several therapeutic strategies is also presented. This review will encourage the scientific community across the globe to come up with better and efficient synthetic protocols and also novel chemical entities along with this core with more potent activity.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/1389557520666201113105940
2021-04-01
2025-07-03
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/1389557520666201113105940
Loading

  • Article Type:
    Review Article
Keyword(s): acute respiratory syndrome; betacoronavirus; COVID-19; epidemiological; FDA; SARS-Cov-2
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test